Craneware’s (CRW) Buy Rating Reaffirmed at Berenberg Bank

Craneware (LON:CRW)‘s stock had its “buy” rating reissued by investment analysts at Berenberg Bank in a report released on Tuesday,Digital Look reports. They currently have a GBX 2,800 ($36.25) target price on the stock. Berenberg Bank’s target price suggests a potential upside of 57.30% from the stock’s current price.

Separately, Shore Capital reaffirmed a “buy” rating on shares of Craneware in a research report on Tuesday.

Craneware Stock Up 0.6 %

Shares of CRW stock traded up GBX 10 ($0.13) during trading on Tuesday, reaching GBX 1,780 ($23.05). The company’s stock had a trading volume of 37,042 shares, compared to its average volume of 85,129. The company has a market capitalization of £764.80 million, a price-to-earnings ratio of 65.76 and a beta of 0.28. Craneware has a 1-year low of GBX 1,670 ($21.62) and a 1-year high of GBX 2,509.20 ($32.49). The company has a debt-to-equity ratio of 12.22, a current ratio of 0.63 and a quick ratio of 1.00. The stock’s 50-day moving average price is GBX 1,967.43 and its 200 day moving average price is GBX 2,090.19.

About Craneware

The Craneware Group, the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group’s Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care.